Page 267 - 2021_06-Haematologica-web

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research
Aleksandr Lazaryan,1 Michelle Dolan,2 Mei-Jie Zhang,3, 4 Hai-Lin Wang,3 Mohamed A. Kharfan-Dabaja,5 David I. Marks,6 Nelli Bejanyan,7 Edward Copelan,8 Navneet S. Majhail,9 Edmund K. Waller,10 Nelson Chao,11 Tim Prestidge,12 Taiga Nishihori,13 Partow Kebriaei,14 Yoshihiro Inamoto,15 Betty Hamilton,16 Shahrukh K. Hashmi,17, 18 Rammurti T. Kamble,19 Ulrike Bacher,20 Gerhard C. Hildebrandt,21 Patrick J. Stiff,22 Joseph McGuirk,23 Ibrahim Aldoss,24 Amer M. Beitinjaneh,25 Lori Muffly,26 Ravi Vij,27 Richard F. Olsson28, 29, Michael Byrne,30 Kirk R. Schultz,31 Mahmoud Aljurf,18 Matthew Seftel,32 Mary Lynn Savoie,33 Bipin N. Savani,34 Leo F. Verdonck,35 Mitchell S. Cairo,36 Nasheed Hossain,37 Vijaya Raj Bhatt,38 Haydar A. Frangoul,39 Hisham Abdel-Azim,40 Monzr Al Malki,24 Reinhold Munker,41 David Rizzieri,42 Nandita Khera,43 Ryotaro Nakamura,44 Olle Ringdén,45 Marjolein van der Poel,46 Hemant S. Murthy,47 Hongtao Liu,48 Shahram Mori,49 Satiro De Oliveira,50 Javier Bolaños-Meade,51 Mahmoud Elsawy,52 Pere Barba,53 Sunita Nathan,54 Biju George,55 Attaphol Pawarode,56 Michael Grunwald,57 Vaibhav Agrawal,58 Youjin Wang,59 Amer Assal,60 Paul Castillo Caro,61 Yachiyo Kuwatsuka,62 Sachiko Seo, 63Celalettin Ustun,64 Ioannis Politikos,65 Hillard M. Lazarus,66 Wael Saber,3 Brenda M. Sandmaier,67 Marcos De Lima,68 Mark Litzow,69 Veronika Bachanova70 and Daniel Weisdorf,71 Acute Leukemia Committee of the CIBMTR3
1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; 2University of Minnesota Medical Center, Minneapolis, MN, USA; 3CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA; 4Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA; 5Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA; 6Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, UK; 7Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA; 8Levine Cancer Institute, Atrium Health, Carolinas HealthCare System, Charlotte, NC, USA; 9Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA; 10Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA; 11Division of Cell Therapy and Hematology, Department of Medicine, Duke University Medical Center, Durham, NC, USA; 12Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand; 13Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; 14Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, TX, USA; 15Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; 16Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA; 17Department of Internal Medicine, Mayo Clinic, MN, USA; 18Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia; 19Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA; 20Department of Hematology, Inselspital, Bern University Hospital, Switzerland; 21Markey Cancer Center, University of Kentucky, Lexington, KY, USA; 22Loyola University Medical Center, Maywood, IL, USA; 23University of Kansas Medical Center, Westwood, KS, USA; 24City of Hope Comprehensive Cancer Center, Duarte, CA, USA; 25University of Miami, Miami, FL, USA; 26Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, USA; 27Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO, USA; 28Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; 29Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden; 30Vanderbilt University Medical Center, Nashville, TN, USA; 31Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia's Children's Hospital, The University of British Columbia, Vancouver, British Columbia, Canada; 32Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada; 33Tom Baker Cancer Centre, Calgary, Alberta, Canada; 34Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; 35Department of Hematology/Oncology, Isala Clinic, Zwolle, the Netherlands; 36Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY, USA; 37Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA; 38The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA; 39The Children's Hospital at TriStar Centennial and Sarah Cannon Research Institute, Nashville, TN, USA; 40Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA; 41Section of Hematology/Oncology, Department of Internal Medicine, Louisiana State University Health Shreveport, Shreveport, LA, USA; 42Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA; 43Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA; 44Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA; 45Translational Cell Therapy Group, CLINTEC ( Clinical Science, Intervention and Technology), Karolinska Institutet, Stockholm Sweden; 46Academische Ziekenhuis Maastricht, Maastricht, the Netherlands; 47Mayo Clinic Florida, Jacksonville, FL, USA; 48University of Chicago Medicine, Chicago, IL, USA; 49Blood & Marrow Transplant Center, Florida Hospital Medical Group, Orlando, FL, USA; 50UCLA Medical Center, Los Angeles, CA, USA; 51The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA; 52QE II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada; 53Hospital Vall d’Hebron, Barcelona, Spain; 54Rush University Medical Center, Chicago, IL, USA; 55Christian Medical College, Vellore, India; 56Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI, USA; 57Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA; 58Division of Hematology- Oncology, Indiana University School of Medicine, Indianapolis, IN, USA; 59National Cancer Institute (NCI), Rockville, MD, USA; 60New York Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA; 61UF Health Shands Children's Hospital, Gainesville, FL, USA; 62Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan; 63Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan; 64Division of Hematology/Oncology/Cell Therapy, Rush University, Chicago, IL, USA; 65Memorial Sloan Kettering Cancer Center, New York, NY, USA; 66Case Western Reserve University, Cleveland, OH, USA; 67Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; 68Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA; 69Division of
haematologica | 2021; 106(8)
2295
ERRATA CORRIGE